Knowledge about effectiveness of general screening for prostatic cancer is limited
Varenhorst, E.; Carlsson, P.; Löfman, O.; Capik, E.; Pedersen, K.
Lakartidningen 89(45): 3835-3838
1992
ISSN/ISBN: 0023-7205 PMID: 1460994 Document Number: 402949
Document emailed within 1 workday
Related Documents
Gu, C.; Chan, C.W.H.; Twinn, S. 2010: How sexual history and knowledge of cervical cancer and screening influence Chinese women's screening behavior in mainland China Cancer Nursing 33(6): 445-453Laufer, M.; Matzkin, H.; Braf, Z.F. 1995: Screening for prostatic cancer Harefuah 129(1-2): 39-43
Schaffer, P.; Renaud, R.; Gérard, A.; Gairard, B. 1992: The general practitioner and screening for cancer of the breast. Study of a sample of 200 general practitioners in the Bas-Rhin Journal de Gynecologie Obstetrique et Biologie de la Reproduction 21(2): 163-171
Nakagawa, S.; Watanabe, M.; Nomoto, T.; Sugimoto, K.; Mikami, K.; Ebisui, K.; Kitamura, K.; Kojima, M.; Saitoh, M.; Watanabe, H. 1997: Mass screening for prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 43(6): 447-452
Meya, D.B.; Manabe, Y.C.; Castelnuovo, B.; Cook, B.A.; Elbireer, A.M.; Kambugu, A.; Kamya, M.R.; Bohjanen, P.R.; Boulware, D.R. 2010: Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 51(4): 448-455
Nakagawa, S. 2002: Evaluation of mass screening for prostatic cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 289-293
Maksimov, V.A.; Pushkar', D.Iu.; Umarov, M.S. 2009: Current outlook on screening of prostatic cancer Urologiia 2009(5): 74-77
Dige, U. 2004: Grey zone-screening for prostatic cancer Ugeskrift for Laeger 166(50): 4619; Author Reply 4619-20
Auclerc, G. 2000: General treatment of metastatic prostatic cancer Annales d'Urologie 34(1): 39-48
Ito, K.; Ohtake, N.; Hatori, M.; Mashimo, T.; Jimbo, S.; Tomaru, Y.; Makino, T.; Yajima, H.; Imai, K.; Yamanaka, H. 1992: Prostatic specific antigen (PA) in mass screening for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 38(11): 1225-1229
Rudebeck, C.E.; Mattsson, B.; Lynöe, N. 2000: About knowledge and knowledge development within general practice. General practitioners meet questions of life in their medical version Lakartidningen 97(3): 170-174
Michalek, A.; Mettlin, C.; Cummings, K.M.; Lane, W.; Priore, R. 1983: Use of a population-based cancer registry in evaluating the effectiveness of a cancer screening program Progress in Clinical and Biological Research 121: 177-185
Varenhorst, E.; Carlsson, P.; Hagström, I.; Lindahl, T.; Löfman, O.; Brage, H.N.; Pedersen, K.; Wägermark, J. 1996: Experiences from six years' examinations of prostatic cancer. Mass screening is not of immediate interest! Lakartidningen 93(35): 2940-2946
Corbusier, A.; Vanden Bossche, M.; Mendes Leal, A.; Simon, J.; Wespes, E.; Van Regemorter, G.; Schulman, C.C. 1989: Reliability of endorectal echography of the prostate in the screening and staging of prostatic cancer Acta Urologica Belgica 57(4): 831-841
Luckett, T.; Phillips, J.; Agar, M.; Lam, L.; Davidson, P.M.; McCaffrey, N.; Boyle, F.; Shaw, T.; Currow, D.C.; Read, A.; Hosie, A.; Lovell, M. 2018: Protocol for a phase III pragmatic stepped wedge cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of screening and guidelines with, versus without, implementation strategies for improving pain in adults with cancer attending outpatient oncology and palliative care services: the Stop Cancer PAIN trial Bmc Health Services Research 18(1): 558
Muzzonigro, G.; Beatrici, V.; Diambrini, M.; Minardi, D.; Rosciani, C.; Possati, L.; Polito, M. 1988: Biology and natural history of prostatic cancer: necessity of early diagnostic screening Bollettino della Societa Italiana di Biologia Sperimentale 64(6): 555-561
Luján Galán, M.; Páez Bordá, A.; Llanes González, L.; Fernández González, I.; Moreno Santurino, A.; Berenguer Sánchez, A. 2000: Characteristics of prostatic cancer undetected in the first assessment of a screening program. Quality control Archivos Espanoles de Urologia 53(10): 900-904
Langhammer, H.; Sintermann, R.; Hör, G.; Pabst, H.W. 1978: Serial bone scintigraphy for assessing the effectiveness of treatment of osseous metastases from prostatic cancer Nuklearmedizin. Nuclear Medicine 17(3): 87-91
Bratt, O.; Abrahamsson, P.A.; Lundgren, R.; Olsson, H.; Kristoffersson, U. 1998: Research progress on hereditary prostatic cancer. Families at risk should be surveyed and screening should be offered Lakartidningen 95(14): 1494-1496
Strohmenger, P. 1980: Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy Zfa. Zeitschrift für Allgemeinmedizin 56(28): 1793-1797